MIT Biotechnology Group

Discussion with RA Capital: Healthcare and Life Science Markets

Join RA Capital Management for a second session of discussions on the healthcare & life science markets, co-hosted with the MIT Biotech Group. RA Capital will introduce you to their scientific approach to investing, walk through their comprehensive landscape maps, and lead the discussion in the underlying science and strategy behind their landscape research. RA Capital Management is a crossover investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. RA Capital researches high interest therapeutic areas and identifies all the relevant technologies on the market or in development, and uses this understanding of a competitive landscape to produce a vision of how the market will likely unfold, determine how companies are positioned to perform, and convey relevance of data to our investment team.

When: July 19th, 2016 @ 5pm
Where: RA Capital Offices (Boston, MA). Specific location details will be provided to confirmed registrants via email.

Space is limited. Please fill out the following registration form and answer the provided questions by July 7th to apply for a spot at the event. http://goo.gl/forms/Yth3h7FmiskGQtIK2